How many insider trades does FilingIQ track for ELAN?

FilingIQ tracks 607 Form 4 insider transactions for ELAN (Elanco Animal Health Inc), covering filings from Sep 24, 2018 onwards. 76 of those were filed in the last 90 days.

Are ELAN insiders net buyers or net sellers?

Across the full Form 4 history for ELAN, 77 transactions (13%) were open-market purchases and 1 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ELAN insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ELAN in?

Elanco Animal Health Inc (ELAN) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $12.99B.

ELAN insider trading

NYSE Healthcare

Elanco Animal Health Inc — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

607

Last 90 days

Buys / sells

13% / 0%

Market cap

$12.99B

About Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio, Credelio Cat, Credelio Plus, Interceptor Plus, Doncit, Drontal, Drontal Plus, and Trifexis trademarks; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. The company also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, it offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, the company offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and TruCan trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. It sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Company website: www.elanco.com

ELAN insider activity at a glance

FilingIQ has scored 607 insider transactions for ELAN since Sep 24, 2018. The most recent filing in our index is dated May 1, 2026.

Across the full history, 77 open-market purchases and 1 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ELAN insider trades is 54.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ELAN trades on FilingIQ Raw filings on SEC EDGAR

Latest ELAN Form 4 filings

Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR

P Aug 12, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading ELAN

Simmons Jeffrey N

23 trades · score 69.0

13F funds holding ELAN

Sofinnova Investments, Inc.

$17.79M · 1.0% of AUM

SANDERS MORRIS HARRIS LLC

$12.37M · 2.5% of AUM

Frequently asked

How many insider trades does FilingIQ track for ELAN?: FilingIQ tracks 607 Form 4 insider transactions for ELAN (Elanco Animal Health Inc), covering filings from Sep 24, 2018 onwards. 76 of those were filed in the last 90 days.
Are ELAN insiders net buyers or net sellers?: Across the full Form 4 history for ELAN, 77 transactions (13%) were open-market purchases and 1 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ELAN insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ELAN in?: Elanco Animal Health Inc (ELAN) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $12.99B.

Methodology & sources

Every ELAN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.